You can find this story in My Bookmarks.Or by navigating to the user icon in the top right.
Caplin Point Laboratories makes a range of branded and generic pharmaceuticals such as antibiotics, non-steroidal anti-inflammatory drugs, ophthalmic, pain management, and anti-ulcer products.
Caplin Point Labs saw 14 lakh shares exchange hands on BSE and NSE combined as compared to the one-week average of three lakh equity shares. The Nifty 50 is expected to consolidate with a hurdle ...